Cargando…
Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy
Cyclophilin A (CypA), which has peptidyl–prolyl cis-trans isomerase (PPIase) activity, regulates multiple functions of cells by binding to its extracellular receptor CD147. The CypA/CD147 interaction plays a crucial role in the progression of several diseases, including inflammatory diseases, corona...
Autores principales: | Han, Jang Mi, Jung, Hye Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408992/ https://www.ncbi.nlm.nih.gov/pubmed/36012604 http://dx.doi.org/10.3390/ijms23169341 |
Ejemplares similares
-
Dealing with the family: CD147 interactions with cyclophilins
por: Yurchenko, Vyacheslav, et al.
Publicado: (2006) -
Cyclophilin–CD147 interactions: a new target for anti-inflammatory therapeutics
por: Yurchenko, V, et al.
Publicado: (2010) -
The Roles of CD147 and/or Cyclophilin A in Kidney Diseases
por: Qu, Xin, et al.
Publicado: (2014) -
Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19
por: Liu, Chenglong, et al.
Publicado: (2020) -
CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance
por: Bakhtiyari, Maryam, et al.
Publicado: (2023)